Breaking News

Tweet TWEET

Cost Increases Drive Higher Drug Trend for Workers' Compensation

       Cost Increases Drive Higher Drug Trend for Workers' Compensation  Spending on Compounded Medications More Than Doubled in 2013  PR Newswire  ST. LOUIS, April 10, 2014  ST. LOUIS, April 10, 2014 /PRNewswire/ --Significant increases in cost per prescription drove drug trend for workers' compensation payers higher in 2013, according to research released this week by Express Scripts (NASDAQ: ESRX). Overall pharmacy spending for workers' compensation increased 9.5 percent, according to the Express Scripts Workers' Compensation Drug Trend Report, primarily from an 8.2 percent jump in cost per prescription. Effective management programs helped keep utilization increases to just over 1 percent.  Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)  Drug trend — defined as the annual rate of increase in pharmacy spending — is the combined effect of changing drug prices and utilization.  The Increasing Challenge of Compounded Medications  Compounded medications used for injured workers saw the most significant increase, with per-user-per-year costs rising 126 percent from 2012. Although these medications account for just 2.7 percent of total pharmacy costs in workers' compensation, the dramatic rise in price impacted overall trend.  Compounded medications are tailored drugs prepared by mixing, combining or altering ingredients. While intended to address special pharmaceutical needs of some injured workers, compounds tend to be significantly more expensive than commercial formulations. In many cases, there are Food and Drug Administration-approved alternatives for compounded medications. Compounded medications can also pose safety issues.  "Without consistent protocols to prepare each drug, compounded drugs can have a greater batch-to-batch variability," said Tim Pokorney, senior vice president, clinical services for workers' compensation at Express Scripts. "This raises significant safety concerns as injured workers could be receiving medication with a higher potency than intended."  Express Scripts helps payers effectively manage the rising costs of compounded medications and ensures safe treatment for injured workers. At the point of sale, clients have the option of reviewing all compounds for authorization. Retrospectively, Express Scripts sends letters to physicians encouraging the use of commercially available, cost-effective alternatives where appropriate. Our research has shown that 42.3 percent of injured workers whose physicians received such communications from Express Scripts discontinued filling compounded medications, thus helping drive down costs for payers.  Narcotics Remain Costliest Therapy Class  Higher prices in other therapy classes also contributed to the growing trend. Key findings of the Workers' Compensation Drug Trend Report include:    oNarcotic analgesics continue to be the costliest therapy class for     work-related injuries, accounting for 32 percent of overall pharmacy     costs. While utilization has declined for the third straight year, costs     continue to rise.   oCost per prescription for hydrocodone-acetaminophen, a long-standing     generic, increased 7.2 percent — twice the increase in 2012.   oNon-steroidal anti-inflammatory drugs — or NSAIDs — which are non-narcotic     medications used to address various pains and conditions, saw a 19.4     percent increase in cost.   oSpecialty medications, including those to prevent blood clots following a     surgery, osteoarthritis and inflammatory conditions, make up only 1     percent of overall pharmacy spend in workers' compensation but pose a     growing cost challenge for payers. The average cost per prescription of a     specialty medication was more than $1,119 in 2013 — nearly nine times that     of the average traditional medication.  The Express Scripts 2013 Workers' Compensation Drug Trend Report is available at:  http://lab.express-scripts.com/drug-trend-report/workers-compensation/workers-compensation-2013-drug-trend-report  Printed copies also will be available at the Risk Management Society (RIMS) Conference, April 27-30 in Denver, in booth #220.  About Express Scripts  Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities — behavioral sciences, clinical specialization and actionable data — to create Health Decision Science^SM, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.  Headquartered in St. Louis, Express Scripts provides integrated pharmacy-benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.  For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.  MEDIA CONTACT: Riddhi Trivedi-St. Clair Office: 314-684-6665 Rtrivedi-st.clair@express-scripts.com  Logo - http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO  SOURCE Express Scripts  Website: http://lab.express-scripts.com/